Showing 2481-2490 of 2784 results for "".
- Endo Pulls Qwo from Markethttps://modernaesthetics.com/news/endo-pulls-qwo-from-market/2473339/Endo International plc is ceasing the production and sale of Endo Aesthetics' Qwo (collagenase clostridium histolyticum-aaes) in light of market concerns about the extent and variability of bruising following initial treatment as well as the potential for prolonged skin discoloratio
- Zubin Meshginpoosh Is Senté's New President and Chief Operating Officerhttps://modernaesthetics.com/news/zubin-meshginpoosh-is-sentes-new-president-and-chief-operating-officer/2473338/Zubin Meshginpoosh is now the President and Chief Operational Officer of Senté. "Zubin has an incredible track record for enabling teams to achieve success in high growth and fast-changing environments," says Faheem Hasnain, Chairman of the Board at Senté, in a n
- Plastic Surgeon Dr. Howard Levinson Named New PSF Presidenthttps://modernaesthetics.com/news/plastic-surgeon-dr-howard-levinson-named-new-psf-president/2473330/Howard Levinson, MD, FACS, is the new president of The Plastic Surgery Foundation (PSF), the research and international activity arm of the American Society of Plastic Surgeons (ASPS). Dr. Levinson took office Oct. 30 in Boston during Plastic Surgery The Meeting, the Soci
- Hydrafacial and Glytone Team Up to Launch New Boosterhttps://modernaesthetics.com/news/hydrafacial-and-glytone-team-up-to-launch-new-booster-1/2473323/The Beauty Health Company’s Hydrafacial is rolling out a new exfoliating booster co-created with Glytone. The Glytone AHA Resurfacing Cellular Booster leverages a unique combination of three alpha hydroxy acids (AHAs) that may help improve the appearance of skin surface and textur
- Teyana Taylor Tapped as New Xeomin Brand Partnerhttps://modernaesthetics.com/news/teyana-taylor-tapped-as-new-xeomin-brand-partner/2473321/Xeomin, an FDA-approved double filtered anti-wrinkle injection to temporarily improve the appearance of frown lines with only the ingredients that work and none that don’t. “I always strive to understand the ingredients in any product I’m using and listen to trusted so
- Hugel Resubmits BLA for Botulaxhttps://modernaesthetics.com/news/hugel-resubmits-bla-for-botulax/2473314/Hugel resubmitted the BLA for its botulinum toxin called Botulax for smoothing glabellar lines to the U.S. FDA. Hugel had received a Complete Response Letter (CRL) from the U.S. FDA last March after submitting the BLA for Botulax (50 and 100 units) to advance into the U.S. market i
- New Indications for SkinPen in the EU and UKhttps://modernaesthetics.com/news/new-indications-for-skinpen-in-the-eu-and-uk/2473310/Crown Aesthetics’ SkinPen Precision scored three new approved indications in the EU and UK. The new&
- New Research Highlights the Efficacy and Safety Profile of Revance's DAXXIFYhttps://modernaesthetics.com/news/new-research-highlights-the-efficacy-and-safety-profile-of-revances-daxxify/2473304/Two new studies highlight the efficacy and safety profile of Revance Therapeutics, Inc.’s newly approved DAXXIFY (DaxibotulinumtoxinA-lanm). Glabellar injection of DAXXIFY showed a positive effect on eyebrow position, with a modest reduction in forehead muscle activity in&nbs
- BTL Introduces EMFACEhttps://modernaesthetics.com/news/btl-introduces-emface/2473301/BTL is taking on the minimally invasive facial aesthetic category with the launch of EMFACE. Emface simultaneously emits both
- Early Postop Microneedling May Improve Surgical Scarshttps://modernaesthetics.com/news/early-postop-microneedling-may-improve-surgical-scars/2473298/Postsurgical scars treated with minimally invasive percutaneous collagen induction in the maturation and remodeling phase may have better aesthetic outcomes, according to a study published in the September issue of Plastic and Reconstructive Surgery. When treatment is